Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
74 participants
OBSERVATIONAL
2017-09-08
2018-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
ZygoRéa is a retrospective and multicentric French study aimed to evaluate survival of patients with mucormycosis admitted in ICU at day-28 after admission. This study will also try also to describe the epidemiology of patients admitted in ICU.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis
NCT02845934
Prognosis of Disseminated and Cerebral Toxoplasmosis Hospitalized in Intensive Care in the Era of PCR Diagnosis
NCT06305468
Risks of Bacterial and Fungal Superinfection in Patients With COVID-19
NCT05256316
Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2.
NCT04488484
Predictors of Infective Endocarditis Among Patients Managed for Staphylococcus Aureus Bacteremia, Particularly Staphylococcus Aureus Bacteriuria, and Time to Blood Culture Positivity
NCT05522764
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
ZygoRéa is a retrospective and multicentric French study aimed to evaluate survival of patients with mucormycosis admitted in ICU at day-28 after admission. This study will also try also to describe the epidemiology of patients admitted in ICU and to evaluate the prognosis of different subgroups of patients according to :
* their clinical characteristics : demographic characteristics, clinical conditions and factors of immunosuppression
* the characteristics of the fungal infection
* the treatment strategy
* the severity of the initial illness, evaluated by severity scores
Twenty-one French ICU are currently including more than 45 patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient hospitalized in intensive care unit during the 2008-2016 period
* Zygomycosis identification in at least 2 solids organs or identification in hemoculture
Exclusion Criteria
* Patient under the law
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Intensive Care Unit - Hospital Amiens
Amiens, , France
Intensive Care Unit - Hospital Angers
Angers, , France
Intensive Care Unit - Hospital Besançon
Besançon, , France
Intensive Care Unit - Hospital Béthune
Béthune, , France
Intensive Care Unit - Hospital Caen
Caen, , France
Intensive Care Unit - Hospital Clermont-Ferrand
Clermont-Ferrand, , France
Intensive Care Unit - Hospital Dijon
Dijon, , France
Intensive Care Unit - Hospital Grenoble Alpes
Grenoble, , France
Intensive Care Unit - Hospital Lille
Lille, , France
Intensive Care Unit - Hospital Lyon
Lyon, , France
Intensive Care Unit - Hospital Montpellier
Montpellier, , France
Intensive Care Unit - Hospital Nantes
Nantes, , France
Intensive Care Unit - Hospital l'Archet - Nice
Nice, , France
Intensive Care Unit - Hospital Bichat
Paris, , France
Intensive Care Unit - Hospital Saint Louis
Paris, , France
Intensive Care Unit - Hospital Tenon
Paris, , France
Intensive Care Unit - Hospital Poitiers
Poitiers, , France
Intensive Care Unit - Hospital Rennes
Rennes, , France
Intensive Care Unit - Hospital Rouen
Rouen, , France
Intensive Care Unit - Hospital Saint Etienne
Saint-Etienne, , France
Intensive Care Unit - Hospital Tours
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZygoRea (38RC17.008)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.